Efficacy and safety of infliximab in patients with autoimmune hepatitis.
Efe C, Lytvyak E, Eşkazan T, Liberal R, Androutsakos T, Turan Gökçe D, Terziroli Beretta-Piccoli B, Janik M, Bernsmeier C, Arvaniti P, Milkiewicz P, Batibay E, Yüksekyayla O, Ergenç I, Arikan Ç, Stättermayer AF, Barutçu S, Cengiz M, Gül Ö, Heurgue A, Heneghan MA, Verma S, Purnak T, Törüner M, Akdogan Kayhan M, Hatemi I, Zachou K, Macedo G, Drenth JPH, Björnsson E, Montano-Loza AJ, Wahlin S, Higuera-de la Tijera F.
Efe C, et al. Among authors: stattermayer af.
Hepatology. 2024 Sep 6. doi: 10.1097/HEP.0000000000001089. Online ahead of print.
Hepatology. 2024.
PMID: 39250458